NESS ZIONA, Israel and CHAPEL HILL, North Carolina, December 4, 2017 /PRNewswire/ —
Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients, today announced that it has raised $30 million. The round was led by Arix Bioscience plc with…
